Dehydroepiandrosterone supplementation in women with adrenal failure: Impact on twenty-four hour GH secretion and IGF-related parameters

Clinical Endocrinology

Volumn 60, Issue 4, 2004, Pages 461-469

  Christiansen, Jens Juel ^a   Gravholt, Claus Højbjerg ^a   Fisker, Sanne ^a   Svenstrup, Birgit ^c   Bennett, Paul ^c   Veldhuis, Johannes ^d   Andersen, Marianne ^b   Christiansen, Jens S ^a   Jørgensen, Jens O L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; PLACEBO; PRASTERONE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE;

ADRENAL INSUFFICIENCY; ADULT; ANALYTICAL PARAMETERS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HORMONAL THERAPY; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; MEASUREMENT; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

ADRENAL INSUFFICIENCY; ADULT; CASE-CONTROL STUDIES; CROSS-OVER STUDIES; DEHYDROEPIANDROSTERONE; DOUBLE-BLIND METHOD; ESTROGENS; FEMALE; GROWTH HORMONE; HALF-LIFE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; RECEPTORS, SOMATOTROPIN; SECRETORY RATE; STATISTICS, NONPARAMETRIC; TESTOSTERONE;

EID: 1842784911     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.01998.x     Document Type: Article

References (48)

1. Albertsson-Wikland, K., Rosberg, S., Karlberg, J. & Groth, T. (1994) Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty. Journal of Clinical Endocrinology and Metabolism, 78, 1195-1201.
2. Arlt, W., Callies, F., van Vlijmen, J.C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H.M. & Allolio, B. (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency [See Comments]. New England Journal of Medicine, 341, 1013-1020.
3. Baumann, G., Amburn, K.D. & Buchanan, T.A. (1987) The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone. Journal of Clinical Endocrinology and Metabolism, 64, 657-660.
4. Bray, M.J., Vick, T.M., Shah, N., Anderson, S.M., Rice, L.W., Iranmanesh, A., Evans, W.S. & Veldhuis, J.D. (2001) Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion. Journal of Clinical Endocrinology and Metabolism, 86, 3143-3149.
5. Campagnoli, C., Biglia, N., Lanza, M.G., Lesca, L., Peris, C. & Sismondi, P. (1994) Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary Report Maturitas, 19, 25-31.
6. Clasey, J.L., Weltman, A., Patrie, J., Weltman, J. Y., Pezzoli, S., Bouchard, C., Thorner, M.O. & Hartman, M.L. (2001) Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. Journal of Clinical Endocrinology and Metabolism, 86, 3845-3852.
7. Dawson-Hughes, B., Stern, D., Goldman, J. & Reichlin, S. (1986) Regulation of growth hormone and somatomedin-c secretion in postmenopausal women. Effect of physiological estrogen replacement. Journal of Clinical Endocrinology and Metabolism, 63, 424-432.
8. Eakman, G.D., Dallas, J.S., Ponder, S.W. & Keenan, B.S. (1996) The Effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion. Journal of Clinical Endocrinology and Metabolism, 81, 1217-1223.
9. European Pharmacopoeia. 3rd Edn. (1997) Council of Europe, Strasbourg.
10. Fisker, S., Frystyk, J., Skriver, L., Vestbo, E., Ho, K.K. & Orskov, H. (1996) A simple, rapid immunometric assay for determination of functional and growth hormone-occupied growth hormone-binding protein in human serum. European Journal of Clinical Investigations, 26, 779-785.
11. Frantz, A.G. & Rabkin, M.T. (1965) Effects of estrogen and sex difference on secretion of human growth hormone. Journal of Clinical Endocrinology and Metabolism, 25, 1470-1480.
12. Friend, K.E., Hartman, M.L., Pezzoli, S.S., Clasey, J.L. & Thorner, M.O. (1996) Both oral and transdermal estrogen increase growth hormone release in postmenopausal women - a clinical research center study. Journal of Clinical Endocrinology and Metabolism, 81, 2250-2256.
13. Frystyk, J., Dinesen, B. & Orskov, H. (1995) Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regulations, 5, 169-176.
14. Gebre-Medhin, G., Husebye, E.S., Mallmin, H., Helstrom, L., Berne, C., Karlsson, F.A. & Kampe, O. (2000) Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease. Clinical Endocrinology, 52, 775-780.
15. Giustina, A. & Veldhuis, J.D. (1998) Pathophysiology of the Neuroregulation of growth hormone secretion in experimental animals and the human. Endocrine Reviews, 19, 717-797.
16. Giustina, A., Scalvini, T., Tassi, C., Desenzani, P., Poiesi, C., Wehrenberg, W.B., Rogol, A.D. & Veldhuis, J.D. (1997) Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. Journal of Clinical Endocrinology and Metabolism, 82, 1210-1219.
17. Gravholt, C.H., Naeraa, R.W., Fisker, S. & Christiansen, J.S. (1997) Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17β-estradiol. Journal of Clinical Endocrinology and Metabolism, 82, 2570-2577.
18. Haffner, S.M., Mykkanen, L., Valdez, R.A. & Katz, M.S. (1993) Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. Journal of Clinical Endocrinology and Metabolism, 77, 1610-1615.
19. Hangaard, J., Andersen, M., Grodum, E., Koldkjar, O. & Hagen, C. (1999) The effects of endogenous opioids and cortisol on thyrotropin and prolactin secretion in patients with addison's disease. Journal of Clinical Endocrinology Metabolism, 84, 1595-1601.
20. Hartman, M.L., Faria, A.C., Vance, M.L., Johnson, M.L., Thorner, M.O. & Veldhuis, J.D. (1991) Temporal structure of in vivo growth hormone secretory events in humans. American Journal of Physiology, 260, E101-E110.
21. Hartman, M.L., Pincus, S.M., Johnson, M.L., Matthews, D.H., Faunt, L.M., Vance, M.L., Thorner, M.O. & Veldhuis, J.D. (1994) Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release. Journal Clinical Investigations, 94, 1277-1288.
22. Hassanab, H.A., Enright, W.J., Tucker, H.A. & Merkel, R.A. (2001) Estrogen and androgen elicit growth hormone release via dissimilar patterns of hypothalamic neuropeptide secretion. Steroids, 66, 71-80.
23. Hobbs, C.J., Plymate, S.R., Rosen, C.J. & Adler, R.A. (1993) Testosterone administration increases insulin-like growth factor-i levels in normal men. Journal of Clinical Endocrinology and Metabolism, 77, 776-779.
24. Hunt, P.J., Gurnell, E.M., Huppert, F.A., Richards, C., Prevost, A.T., Wass, J.A.H., Herbert, J. & Chatterjee, V.K. (2000) Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double-blind trial. Journal of Clinical Endocrinology and Metabolism, 85, 4650-4656.
25. Jaffe, C.A., Ocampo-Lim, B., Guo, W., Krueger, K., Sugahara, I., DeMott-Friberg, R., Bermann, M. & Barkan, A.L. (1998) Regulatory mechanisms of growth hormone secretion are sexually dimorphic. Journal of Clinical Investigation, 102, 153-164.
26. Johannsson, G., Burman, P., Wiren, L., Engstrom, B.E., Nilsson, A.G., Ottosson, M., Jonsson, B., Bengtsson, B.A. & Karlsson, F.A. (2002) Low-dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism, 87, 2046-2052.
27. Kam, G.Y., Leung, K.C., Baxter, R.C. & Ho, K.K. (2000) Estrogens exert route-and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex. Journal of Clinical Endocrinology and Metabolism, 85, 1918-1922.
28. Labrie, F., Van Bélanger, A.L.T., Labrie, C., Simard, J., Cusan, L., Gomez, J.L. & Candas, B. (1998) DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues. Its Role During Aging Steroids, 63, 322-328.
29. Leung, K.C., Doyle, N., Ballesteros, M., Sjogren, K., Watts, C.K.W., Low, T.H., Leong, G.M., Ross, R.J.M. & Ho, K.K.Y. (2003) Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proceedings of the National Academy of Sciences USA, 0337600100.
30. Lieman, H.J., Adel, T.E., Forst, C., von Hagen, S. & Santoro, N. (2001) Effects of aging and estradiol supplementation on GH axis dynamics in women. Journal of Clinical Endocrinology and Metabolism, 86, 3918-3923.
31. Liu, L., Merriam, G.R. & Sherins, R.J. (1987) Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism, 64, 651-656.
32. Lovas, K., Gebre-Medhin, G., Trovik, T.S., Fougner, K.J., Uhlving, S., Nedrebo, B.G., Myking, O.L., Kampe, O. & Husebye, E.S. (2003) Replacement of dehydroepiandrosterone in adrenal failure, no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. Journal of Clinical Endocrinology and Metabolism, 88, 1112-1118.
33. Lykkesfeldt, G., Bennett, P., Lykkesfeldt, A.E., Micic, S., Moller, S. & Svenstrup, B. (1985) Abnormal androgen and oestrogen metabolism in men with steroid sulphatase deficiency and recessive x-linked ichthyosis. Clinical Endocrinology, 23, 385-393.
34. Massa, G., Igout, A., Rombauts, L., Frankenne, F. & Vanderschueren-Lodeweyckx, M. (1993) Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-i in non-pregnant and pregnant women. Clinical Endocrinology, 39, 569-575.
35. Mauras, N., Rogol, A.D. & Veldhuis, J.D. (1990) RiaIncreased HGH production rate after low-dose estrogen therapy in prepubertal girls with Turner's syndrome. Pediatrics Research, 28, 626-630.
36. Metzger, D.L. & Kerrigan, J.R. (1993) Androgen receptor blockade with flutamide enhances growth hormone secretion in late pubertal males. Evidence for independent actions of estrogen and androgen. Journal of Clinical Endocrinology and Metabolism, 76, 1147-1152.
37. Metzger, D.L. & Kerrigan, J.R. (1994) Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys. Evidence for a stimulatory role of endogenous estrogens during male adolescence. Journal of Clinical Endocrinology and Metabolism, 79, 513-518.
38. Pincus, S.M. & Keefe, D.L. (1992) Quantification of hormone pulsatility via an approximate entropy algorithm. American Journal of Physiology, 262, E741-E754.
39. Pincus, S.M., Gevers, E.F., Robinson, I.C., van den Berg, G., Roelfsema, F., Hartman, M.L. & Veldhuis, J.D. (1996) Females secrete growth hormone with more process irregularity than males in both humans and rats. American Journal of Physiology, 270, E107-E115.
40. Rose, S.R., Municchi, G., Barnes, K.M., Kamp, G.A., Uriarte, M.M., Ross, J.L., Cassorla, F. & Cutler, G.B. Jr (1991) Spontaneous growth hormone secretion increases during puberty in normal girls and boys. Journal of Clinical Endocrinology and Metabolism, 73, 428-35.
41. Ulloa-Aguirre, A., Blizzard, R.M., Garcia-Rubi, E., Rogol, A.D., Link, K., Christie, C.M., Johnson, M.L. & Veldhuis, J.D. (1990) Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency or the GH half-life. Journal of Clinical Endocrinology and Metabolism, 71, 846-854.
42. Vahl, N., Jorgensen, J.O., Skjaerbaek, C., Veldhuis, J.D., Orskov, H. & Christiansen, J.S. (1997) Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. American Journal of Physiology, 272, E1108-E1116.
43. Veldhuis, J.D., Carlson, M.L. & Johnson, M.L. (1987) The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proceedings of the National Academy of Sciences of the USA, 84, 7686-7690.
44. Veldhuis, J.D., Metzger, D.L., Martha, P.M.J., Mauras, N., Kerrigan, J.R., Keenan, B., Rogol, A.D. & Pincus, S.M. (1997) Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human. Evidence from pubertal pathophysiology and sex-steroid hormone replacement. Journal of Clinical Endocrinology and Metabolism, 82, 3414-3420.
45. Weissberger, A.J. & Ho, K.K. (1993) Activation of the somatotropic axis by testosterone in adult males. Evidence for the role of aromatization. Journal of Clinical Endocrinology and Metabolism, 76, 1407-1412.
46. Weissberger, A.J., Ho, K.K. & Lazarus, L. (1991) Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor i, and gh-binding protein in postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 72, 374-381.
47. Wolthers, Troels, Hoffman, David, M., Nugent, Ailish, G., Duncan, Mark, W., Umpleby, Margot & Ho, Ken, K.Y. (2001) Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. American Journal of Pediatric Endocrinology and Metabolism, 281, E1191-E1196.
48. Young, J., Couzinet, B., Nahoul, K., Brailly, S., Chanson, P., Baulieu, E.E. & Schaison, G. (1997) Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. Journal of Clinical Endocrinology and Metabolism, 82, 2578-2585.